Bayesian designs and the control of frequentist characteristics: a practical solution
DOI10.1111/BIOM.12226zbMATH Open1419.62463OpenAlexW1909633789WikidataQ45097687 ScholiaQ45097687MaRDI QIDQ3465748FDOQ3465748
Authors: Steffen Ventz, Lorenzo Trippa 
Publication date: 22 January 2016
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.12226
Recommendations
- Combining Bayesian experimental designs and frequentist data analyses: motivations and examples
- Bayesian designs with frequentist and Bayesian error rate considerations
- Control of type I error rates in Bayesian sequential designs
- Bayesian adaptive designs for clinical trials
- Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies
Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05) Bayesian problems; characterization of Bayes procedures (62C10)
Cites Work
- Approaches for Optimal Sequential Decision Analysis in Clinical Trials
- The relationship between the power prior and hierarchical models
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
- Bayesian Optimal Design for Phase II Screening Trials
- Simulation-based sequential Bayesian design
- Bayesian adaptive methods for clinical trials
- Why Isn't Everyone a Bayesian?
- Reconciling Bayesian and Frequentist Evidence in the One-Sided Testing Problem
- Statistical monitoring of clinical trials. A unified approach.
- Bayesian randomized clinical trials: A decision-theoretic sequential design
- Doing What Comes Naturally: Interpreting a Tail Area as a Posterior Probability or as a Likelihood Ratio
- Title not available (Why is that?)
- Title not available (Why is that?)
- Early Stopping to Accept H 0 Based on Conditional Power: Approximations and Comparisons
- Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs
- Sequential Trials, Sequential Analysis and the Likelihood Principle
- One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
- Bayesian enrichment strategies for randomized discontinuation trials
- Screening designs for drug development
Cited In (14)
- Combining Bayesian experimental designs and frequentist data analyses: motivations and examples
- Control of type I error rates in Bayesian sequential designs
- Bayesian designs with frequentist and Bayesian error rate considerations
- Bayesian Response-Adaptive Designs for Basket Trials
- Bayesian uncertainty directed trial designs
- An Approximation Approach for Response-Adaptive Clinical Trial Design
- A dynamic power prior for Bayesian non-inferiority trials
- Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
- Frequentist test in Bayesian two-stage designs applied in experimental trials
- Frequentist operating characteristics of Bayesian optimal designs via simulation
- A Bayesian multi-arm multi-stage clinical trial design incorporating information about treatment ordering
- Borrowing historical information for non-inferiority trials on Covid-19 vaccines
- Optimality of testing procedures for survival data in the nonproportional hazards setting
- Inference and Decision Making for 21st-Century Drug Development and Approval
Uses Software
This page was built for publication: Bayesian designs and the control of frequentist characteristics: a practical solution
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3465748)
